Amgen (AMGN) Financial Statements & Analysis

Amgen (AMGN) Income Statement

Amgen reported revenue of $36.75B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 10.0% from $33.42B a year earlier. Net income was $7.71B, up 88.5% year over year, a net margin of 21.0%. Gross margin was 67.2% and operating margin 24.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $10.05B, up 9.7% from the same quarter a year earlier.

Amgen Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Amgen Inc. income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	36.75	33.42	28.19	26.32	25.98	25.42	23.36	23.75	22.85
Cost of Revenue	12.04	12.86	8.42	6.38	6.45	6.16	4.36	4.10	4.07
Gross Profit	24.71	20.57	19.78	19.92	19.53	19.27	19.01	19.65	18.78
Operating Expenses
Research & Development	7.27	5.96	4.78	4.43	6.32	4.21	4.12	3.74	3.56
Selling, General & Administrative	7.05	7.10	6.18	5.41	5.37	5.73	5.15	5.33	4.87
Operating Expenses	15.63	13.31	11.84	10.35	11.89	10.13	9.33	9.38	8.81
Operating Income	9.08	7.26	7.90	9.57	7.64	9.14	9.67	10.26	9.97
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.13	0.00	0.00	0.59	0.67	0.93
Interest Expense	2.76	3.16	2.88	-1.53	1.20	1.26	1.29	1.39	1.30
Other Income/Expense	2.65	-2.65	-0.04	-2.22	-0.94	-1.01	-0.54	-0.72	-0.38
Income
Income Before Tax	8.98	4.61	7.86	7.35	6.70	8.13	9.14	9.55	9.60
Income Tax Expense	1.27	0.52	1.14	0.79	0.81	0.87	1.30	1.15	7.62
Net Income	7.71	4.09	6.72	6.55	5.89	7.26	7.84	8.39	1.98
Net Income - Continuous Operations	7.71	4.09	6.72	6.55	5.89	7.26	7.84	8.39	1.98
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	16.90	13.36	14.80	13.36	11.30	13.00	12.63	12.88	12.86
EBIT	11.73	9.68	9.82	10.10	9.15	-	-	-	-
Depreciation & Amortization	5.17	5.59	4.07	3.26	3.40	3.60	2.21	1.95	1.96
Earnings Per Share
Basic EPS	14.00	8.00	13.00	12.00	10.00	12.00	13.00	13.00	3.00
Diluted EPS	14.00	8.00	12.00	12.00	10.00	12.00	13.00	13.00	3.00
Basic Shares Outstanding	0.54	0.54	0.54	0.54	0.57	0.59	0.61	0.66	0.73
Diluted Shares Outstanding	0.54	0.54	0.54	0.54	0.57	0.59	0.61	0.67	0.74

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Amgen Financial Statements

What was Amgen's revenue in fiscal 2025?

Amgen reported revenue of $36.75B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 10.0% from $33.42B a year earlier.

Is Amgen profitable?

Yes. Amgen earned net income of $7.71B in fiscal 2025, a net margin of 21.0%. In fiscal 2024 it earned $4.09B.

What is Amgen's operating margin?

Amgen's operating income was $9.08B on revenue of $36.75B in fiscal 2025, an operating margin of 24.7%, compared with 21.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition